We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.62%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$483M
AUM Growth
+$36.3M
(+8.1%)
Cap. Flow
+$48.7M
Cap. Flow
% of AUM
10.09%
Top 10 Holdings %
Top 10 Hldgs %
39.82%
Holding
168
New
65
Increased
31
Reduced
19
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLT
CATALENT, INC.
CTLT
|
+$11.4M |
| 2 |
Itron
ITRI
|
+$9.25M |
| 3 |
Fluor
FLR
|
+$8.9M |
| 4 |
Pacific Biosciences
PACB
|
+$7.8M |
| 5 |
First Solar
FSLR
|
+$6.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$12.3M |
| 2 |
Tenet Healthcare
THC
|
+$10.3M |
| 3 |
CTLP
Cantaloupe
CTLP
|
+$9.1M |
| 4 |
Pacira BioSciences
PCRX
|
+$9.04M |
| 5 |
Guardant Health
GH
|
+$8.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.4% |
| 2 | Industrials | 8.27% |
| 3 | Healthcare | 8.06% |
| 4 | Materials | 7.9% |
| 5 | Utilities | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
First Solar
FSLR
$22.1B
| $33.8M | 7.01% |
225,900
+44,900
| +25% | +$6.65M |
|
|
STKL
2
DELISTED
SunOpta
STKL
| $22.7M | 4.7% |
2,691,000
+12,500
| +0.5% | +$118K |
|
3
Bioceres Crop Solutions
BIOX
$21.4M
| $22.3M | 4.62% |
1,854,000
+143,382
| +8% | +$1.86M |
|
4
Sunrun
RUN
$2.27B
| $21.7M | 4.48% |
901,500
+84,400
| +10% | +$2.25M |
|
5
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$32.5B
| $19.6M | 4.07% |
+200,000
| New | +$19M |
|
6
CALL
Walt Disney
DIS
$167B
| $17.8M | 3.69% |
205,000
+195,000
| +1,950% | +$18.7M |
|
|
EVA
7
DELISTED
Enviva Inc.
EVA
| $13.8M | 2.85% |
259,750
+99,750
| +62% | +$5.7M |
|
|
CTLP
8
DELISTED
Cantaloupe
CTLP
| $13.7M | 2.84% |
3,150,000
-2,567,121
| -45% | -$9.1M |
|
9
Harmonic Inc
HLIT
$1.22B
| $13.6M | 2.81% |
1,036,300
-78,200
| -7% | -$1.09M |
|
|
10
Itron
ITRI
$4.33B
| $13.3M | 2.75% |
262,250
+187,250
| +250% | +$9.25M |
|
11
Altimmune
ALT
$580M
| $11.6M | 2.4% |
704,750
-223,200
| -24% | -$2.51M |
|
12
CALL
VanEck Gold Miners ETF
GDX
$23.5B
| $11.5M | 2.37% |
+400,000
| New | +$10.7M |
|
13
Flex
FLEX
$41B
| $10.5M | 2.18% |
650,894
-44,985
| -6% | -$675K |
|
14
Surgery Partners
SGRY
$2.08B
| $10.4M | 2.16% |
375,000
-130,000
| -26% | -$3.44M |
|
15
Agnico Eagle Mines
AEM
$75.4B
| $10.4M | 2.15% |
200,000
+75,000
| +60% | +$3.54M |
|
|
16
CALL
Itron
ITRI
$4.33B
| $10.1M | 2.1% |
+200,000
| New | +$9.88M |
|
17
EOG Resources
EOG
$77.5B
| $9.71M | 2.01% |
75,000
+10,000
| +15% | +$1.33M |
|
|
18
Fluor
FLR
$6.99B
| $9.66M | 2% |
+278,600
| New | +$8.9M |
|
|
CTLT
19
DELISTED
CATALENT, INC.
CTLT
| $9.48M | 1.96% |
+210,500
| New | +$11.4M |
|
|
AMPS
20
DELISTED
Altus Power
AMPS
| $9.45M | 1.96% |
1,450,000
-408,500
| -22% | -$3.34M |
|
21
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $9.19M | 1.9% |
110,450
+35,000
| +46% | +$2.83M |
|
22
Atlassian
TEAM
$24.9B
| $8.58M | 1.78% |
66,650
+28,050
| +73% | +$4.47M |
|
23
SentinelOne
S
$6.31B
| $8.39M | 1.74% |
575,200
+136,200
| +31% | +$2.52M |
|
24
Vistra
VST
$50.1B
| $8.18M | 1.69% |
352,500
-65,000
| -16% | -$1.5M |
|
25
Aehr Test Systems
AEHR
$2.51B
| $8.06M | 1.67% |
401,000
+207,000
| +107% | +$4.43M |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
FWM
Ardsley Advisory Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Ardsley Advisory Partners held 168 positions worth $483M, up 8.1% from $447M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Ardsley Advisory Partners deployed $48.7M of net new capital in Q4 2022, opening 65 new positions and adding to 31 existing holdings. Its largest new stake was CATALENT, INC.: 210,500 shares worth $9.48M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Cantaloupe, an estimated $9.1M trimmed.
- Ardsley Advisory Partners's largest Q4 2022 buy was CATALENT, INC.: 210,500 shares worth $9.48M.
- Ardsley Advisory Partners added most to Itron in Q4 2022, an estimated $9.25M increase.
- Ardsley Advisory Partners's biggest Q4 2022 reduction was Cantaloupe, cutting an estimated $9.1M.
- Ardsley Advisory Partners fully exited STAAR Surgical in Q4 2022, selling an estimated $12.3M.
- Ardsley Advisory Partners's ten largest holdings make up 40% of its $483M portfolio in Q4 2022.
- Ardsley Advisory Partners opened 65 new positions and closed 49 in Q4 2022.
- Ardsley Advisory Partners's portfolio value rose 8.1% quarter-over-quarter to $483M.
Based on Ardsley Advisory Partners's 13F filing for Q4 2022, filed 14 Feb 2023.